Heikkilä, Juha Markus
Bergman, Paula
Jantunen, Juha
Salimäki, Johanna
Pohjanoksa-Mäntylä, Marika
Kauppi, Paula
Funding for this research was provided by:
University of Helsinki including Helsinki University Central Hospital
Article History
Received: 27 November 2022
Accepted: 31 July 2023
First Online: 18 August 2023
Declarations
:
: The study was conducted according to the Finnish National Advisory Board on Research Integrity guidelines and the Helsinki declaration. The study was granted ethical approval (153/13/03/01/2010) by the Ethical Committee of Helsinki University Hospital (Research Ethics Committee of the Faculty of Medicine).Participants gave their informed verbal consent to participate in the study to a pharmacist while visiting a community pharmacy. The parents gave their permission and an informed verbal consent for the participants of 5–17 years (the parent who was visiting the pharmacy to purchase the medicine gave his/her verbal permission and filled in the questionnaire with the pharmacist). The abovementioned procedure to obtain informed verbal consent from participants (or from the participant’s parent) to participate in the study was approved by the Ethical Committee of Helsinki University Hospital when granting ethical approval (153/13/03/01/2010) for the study. All data were collected, handled, and analysed anonymously without any identifiable patient data. No identifiable personal data were asked or recorded.
: Not applicable.
: JH has been employee of AstraZeneca Oy since 2019. The other authors report no conflicts of interest in this work.